ArticleEClinicalMedicine2022

Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study.

Zhe-Yu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.